Replies to post #9088 on Momenta Pharmaceuticals, Inc. (MNTA)

[iwfal]

M402 in combination with gemcitabine almost
completely inhibited primary and metastatic tumor growth,

Sounds like a drug that will not have the typical ORR response - only a PFS type of response. Will make the ph i and ii more difficult.

[floblu14]

Phase 1/2 Study Design M402 (in case you missed it)
http://www.momentapharma.com/ASCO_2012_poster_4056.pdf

A biggy!! LOL